Mortality is not associated with paclitaxel-coated devices usage in peripheral arterial disease of lower extremities
Abstract A recent meta-analysis addressed increased risk of death following revascularization with paclitaxel-coated devices in femopopliteal artery. We evaluated differences in all-cause mortality and amputation free survival between peripheral arterial disease (PAD) patients who were treated with...
Guardado en:
Autores principales: | Dai Sik Ko, Gi Hwan Bae, Sang Tae Choi, Jaehun Jung, Jin Mo Kang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5385bb32fc7c46a18db1bdfa67fa9bbe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Paclitaxel Exposure and Dosage of Drug-coated Devices for the Treatment of Femoropopliteal Peripheral Artery Disease
por: Ceazón T Edwards, et al.
Publicado: (2021) -
Study on the Lower Extremity Rehabilitation Device RHleg
por: Dao Minh Duc, et al.
Publicado: (2021) -
Paclitaxel- and Sirolimus-coated Balloons in Peripheral Artery Disease Treatment: Current Perspectives and Concerns
por: Masayuki Mori, et al.
Publicado: (2021) -
Combination of Exercise Testing Criteria to Diagnose Lower Extremity Peripheral Artery Disease
por: Olivier Stivalet, et al.
Publicado: (2021) -
Lower extremity MRI following 10-week supervised exercise intervention in patients with diabetic peripheral neuropathy
por: Nathan Davis, et al.
Publicado: (2021)